Abstract accepted at the American Society of Clinical Oncology (ASCO) Annual Meeting - the world’s largest and most prestigious medical ...

IDE supplement expands trial to the other primary standard-of-care chemotherapy for pancreatic cancer patients, alongside mFOLFIRINOX -- IDE ...

Alpha Tau Medical Ltd ( (DRTS)) has issued an announcement. On April 23, 2026, Alpha Tau Medical announced that it has successfully treated the first European pancreatic cancer patient with its Alpha ...

Rocket Lab offers a compelling growth narrative, contingent on sustained 40–50%+ revenue growth. Read more on the buy thesis ...

Targeted Alpha Therapies present growth opportunities by targeting cancer with specificity and efficacy. Key prospects include advancements in clinical trials, exploring combination therapies, ...

The rise of a new generation of radiotherapies means we will soon need much greater quantities of radioactive atoms. That's ...

Convergent Therapeutics Inc., a clinical-stage biotechnology company developing next-generation alpha-emitting radioantibodies for the treatment of advanced prostate cancer, today announced that ...

New research reveals that sunburn may be caused by RNA damage, not DNA, challenging long-held beliefs about UV exposure.

Alpha Centauri, the nearest star system to our own, sits 4.37 light-years away. At the speed Voyager 1 travels, reaching it ...

Rocket Lab unveils ST-HP star tracker for long-duration spacecraft, delivering <1 arcsecond pointing and 50 kRad tolerance.

Yasmine Chinnery has always been the one to lift up those around her. Now she’s learning to receive that same support.

Perspective Therapeutics, Inc. (“Perspective” or the “Company”) (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering advanced treatments for cancers throughout the body, today ...